Randomized, Double-Blind Phase 1 Safety and Tolerability Study of Pafuramidine Maleate (DB289) in Healthy Subjects

Update Il y a 4 ans
Reference: NCT00619346

Woman and Man

Extract

This is a phase 1 study to establish the safety and tolerability profile of pafuramidine maleate 100 mg BID administered orally for 14 days to healthy subjects


Inclusion criteria

  • Healthy

Links